Wettbewerbsrecht Blog

Official Blog of the European Competition and Regulatory Law Review (CoRe)

Der CoRe Blog bietet ein Austauschformat für aktuelle Analysen der Entwicklungen im EU-Wettbewerbsrecht. Er ist der Blog-Begleiter der vierteljährlich erscheinenden, mit einem doppelten Peer-Review-Verfahren versehenen European Competition and Regulatory Law Review (CoRe). Der CoRe-Blog füllt die Lücken, die eine viermal jährlich erscheinende Zeitschrift nicht schließen kann: unmittelbare Aktualisierungen und Analysen der neuesten Entwicklungen im EU-Wettbewerbs- und Regulierungsrecht und die Möglichkeit, diese Entwicklungen über unseren Kommentarbereich direkt mit anderen Experten zu diskutieren.

Wir möchten hören, was Sie über die aktuellen Themen im EU-Wettbewerbs- und Regulierungsrecht denken. Reichen Sie Ihren eigenen Beitrag (500-2000 Wörter) als externer Autor ein. Der Autor des beliebtesten Blogbeitrags im letzten Quartal wird in der CoRe-Zeitschrift veröffentlicht und erhält ein kostenloses Exemplar einer Ausgabe seiner Wahl.

Jetzt abonnieren!

- pharmaceuticals ×

Reverse payment settlements in the European Union after the Generics (UK) judgment – perplexing legal uncertainty

On January 30th, the Court of Justice (“the Court”) released its judgment in the Generics (UK) case. In a preliminary ruling procedure, the UK Competition Appeal Tribunal asked the Court to provide guidance on how to interpret Article 101 TFEU with regard to patent settlements between pharmaceutical companies. The judgment has considerable legal significance as it represents the very first […]

Innovation in EU merger control

The Commission’s assessment of the effects of mergers on innovation has fascinated scholars and practitioners for the last two years or so. On 12 April 2018, the Commission’s Deputy Director General for Mergers Carles Esteva Mosso comprehensively addressed the issue at the Spring Meeting of the ABA Section of Antitrust Law. This blogpost traces earlier developments and gleans new insights […]
Anja Naumann

Blog Editor

LL.M., PhD, currently legal trainee at the Higher Regional Court of Berlin.

>> Anja’s CoRe Blog posts >>

Daniel Mandrescu

Blog editor

Assistant Professor EU competition law, Europa Institute, Leiden University

>> Daniel’s CoRe blog posts >>

Friso Bostoen

Blog Editor

Assistant Professor of Competition Law and Digital Regulation, Tilburg University

Friso Bostoen is an assistant professor of competition law and digital regulation at Tilburg University. Previously, he was a Max Weber Fellow at the European University Institute. He holds degrees from KU Leuven (PhD, LLM) and Harvard University (LLM). Friso’s research focuses on antitrust enforcement in digital markets. His work has resulted in numerous international publications, presentations, and awards (including the AdC Competition Policy Award 2019 and the Concurrences PhD Award 2022). In addition, Friso edits the CoRe Blog and hosts the Monopoly Attack podcast.

>> Friso’s CoRe Blog posts >>

Nelly Stratieva

Head of Editorial Department and Data Protection Officer

Responsible for EStAL (European State Aid Law Quarterly), EPPPL (European Public Private Partnership Law Review) and CoRe (European Competition and Regulatory Law Review). Overseeing Lexxion Publisher’s privacy and data protection compliance.

Parsa Tonkaboni
Picture Rita Paukste
Rita Paukste

Former Blog Editor

Senior Associate, Motieka & Audzevicius PLP, Vilnius

>> Rita’s CoRe Blog posts >>

- pharmaceuticals ×

Reverse payment settlements in the European Union after the Generics (UK) judgment – perplexing legal uncertainty

On January 30th, the Court of Justice (“the Court”) released its judgment in the Generics (UK) case. In a preliminary ruling procedure, the UK Competition Appeal Tribunal asked the Court to provide guidance on how to interpret Article 101 TFEU with regard to patent settlements between pharmaceutical companies. The judgment has considerable legal significance as it represents the very first […]

Innovation in EU merger control

The Commission’s assessment of the effects of mergers on innovation has fascinated scholars and practitioners for the last two years or so. On 12 April 2018, the Commission’s Deputy Director General for Mergers Carles Esteva Mosso comprehensively addressed the issue at the Spring Meeting of the ABA Section of Antitrust Law. This blogpost traces earlier developments and gleans new insights […]

- pharmaceuticals ×

Reverse payment settlements in the European Union after the Generics (UK) judgment – perplexing legal uncertainty

On January 30th, the Court of Justice (“the Court”) released its judgment in the Generics (UK) case. In a preliminary ruling procedure, the UK Competition Appeal Tribunal asked the Court to provide guidance on how to interpret Article 101 TFEU with regard to patent settlements between pharmaceutical companies. The judgment has considerable legal significance as it represents the very first […]

Innovation in EU merger control

The Commission’s assessment of the effects of mergers on innovation has fascinated scholars and practitioners for the last two years or so. On 12 April 2018, the Commission’s Deputy Director General for Mergers Carles Esteva Mosso comprehensively addressed the issue at the Spring Meeting of the ABA Section of Antitrust Law. This blogpost traces earlier developments and gleans new insights […]

Sie möchten einen Beitrag einreichen oder zur Weiterentwicklung des CoRe Blogs beitragen? Weitere Details finden Sie auf der englischsprachigen Seite.

Gastbeitrag einreichen

Abonnieren Sie unseren Newsletter, um aktuelle Informationen über rechtliche Entwicklungen, bevorstehende Konferenzen, Seminare und Publikationen zu erhalten.

Bleiben Sie auf dem Laufenden: Newsletter Abonnement